05/10/2024
6:22 PM | Alpine Immune Sciences (Issuer)
FUHS ULRICH MARTIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:24 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:25 PM | Alpine Immune Sciences (Issuer)
DURAND REMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:26 PM | Alpine Immune Sciences (Issuer)
PENG STANFORD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
7:01 AM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-T/A | |
05/10/2024
7:30 AM | Alpine Immune Sciences (Subject)
| Form SC 14D9/A | |
05/09/2024
8:13 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/09/2024
3:22 PM | Alpine Immune Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:09 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:54 AM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-T/A | |
05/07/2024
7:30 AM | Alpine Immune Sciences (Subject)
| Form SC 14D9/A | |
04/30/2024
3:20 PM | Alpine Immune Sciences (Subject)
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by)
| Form SC 13D/A | |
04/29/2024
5:08 PM | Alpine Immune Sciences (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
04/25/2024
6:48 PM | Alpine Immune Sciences (Filer)
| Form 10-K/A | |
04/22/2024
3:27 PM | Alpine Immune Sciences (Subject)
| Form SC 14D9 | |
04/22/2024
3:15 PM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-T | |
04/11/2024
3:08 PM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-C | |
04/10/2024
4:22 PM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-C | |
04/10/2024
4:27 PM | Alpine Immune Sciences (Subject)
| Form SC14D9C | |
04/10/2024
4:10 PM | Alpine Immune Sciences (Subject)
| Form SC14D9C | |
04/10/2024
3:26 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
6:11 PM | Alpine Immune Sciences (Issuer)
FUHS ULRICH MARTIN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
3:31 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
7:04 AM | Alpine Immune Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2024
7:05 AM | Alpine Immune Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
11:29 AM | Alpine Immune Sciences (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
3:43 PM | Alpine Immune Sciences (Subject)
Omega Fund VI, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
3:36 PM | Alpine Immune Sciences (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:22 AM | Alpine Immune Sciences (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
01/29/2024
6:04 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:54 PM | Alpine Immune Sciences (Issuer)
Decheng Capital China Life Sciences USD Fund III, L.P. (Reporting)
Decheng Capital Management III , LLC (0001747821) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:48 PM | Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:36 PM | Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:39 PM | Alpine Immune Sciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:06 PM | Alpine Immune Sciences (Issuer)
DURAND REMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:07 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:08 PM | Alpine Immune Sciences (Issuer)
PENG STANFORD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:08 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:01 PM | Alpine Immune Sciences (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:02 PM | Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The most important AI company you've never heard of (Ad) Because this small company solves the BIGGEST problem with Nvidia's AI chips.
Already, Amazon, Microsoft, Google and others are lining up to get this company's products. Get the full story on this secret AI company poised for massive growth |
01/04/2024
6:03 PM | Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:03 PM | Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:05 PM | Alpine Immune Sciences (Issuer)
Drappa Jorn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:06 PM | Alpine Immune Sciences (Issuer)
Hernday Natasha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:07 PM | Alpine Immune Sciences (Issuer)
CONWAY ROBERT E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
6:32 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:20 PM | Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:16 PM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/29/2023
3:18 PM | Alpine Immune Sciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
8:07 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
4:00 PM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
4:02 PM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/21/2023
6:35 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
6:34 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:23 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:50 PM | Alpine Immune Sciences (Subject)
GOLD MITCHELL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
8:20 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:33 PM | Alpine Immune Sciences (Subject)
Rickey James Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:36 PM | Alpine Immune Sciences (Subject)
Rickey James Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
4:30 PM | Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
8:02 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
8:00 PM | Alpine Immune Sciences (Subject)
GOLD MITCHELL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
6:31 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:00 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
9:25 AM | Alpine Immune Sciences (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
11/14/2023
3:16 PM | Alpine Immune Sciences (Subject)
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by)
| Form SC 13D/A | |
11/13/2023
8:15 PM | Alpine Immune Sciences (Subject)
Alpine ImmunoSciences, L.P. (Filed by)
| Form SC 13D/A | |
11/13/2023
7:51 AM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
11/08/2023
4:20 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:18 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
8:37 PM | Alpine Immune Sciences (Subject)
| Form FWP | |
11/06/2023
3:20 PM | Alpine Immune Sciences (Subject)
Rickey James Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
5:02 AM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
5:05 AM | Alpine Immune Sciences (Filer)
| Form 424B5 | |
11/02/2023
8:12 AM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:02 PM | Alpine Immune Sciences (Subject)
Cormorant Asset Management, LP (Filed by)
| Form SC 13G | |
10/04/2023
4:11 PM | Alpine Immune Sciences (Issuer)
Dummer Wolfgang (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
4:14 PM | Alpine Immune Sciences (Issuer)
Dummer Wolfgang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
11:15 PM | Alpine Immune Sciences (Filer)
| Form EFFECT | |
08/14/2023
3:18 PM | Alpine Immune Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
3:22 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
